Alvotech Tech Stack
Biosimilar developer scaling manufacturing and regulatory infrastructure
Alvotech develops biosimilar therapeutics at manufacturing scale, with active infrastructure modernization across quality, safety, and regulatory systems. The hiring velocity is accelerating with research roles (28 open positions) dominating the pipeline, paired with targeted builds in data (7), manufacturing (7), and engineering (4)—a mix that signals concurrent pushes toward both development throughput and operational compliance. The project list (validation protocols, bioanalytical lab setup, safety data management, media fill simulations, technology transfer) and pain-point concentration (CGMP compliance, inspection readiness, regulatory audit) indicate a company scaling from early-stage R&D toward GMP-certified production and regulatory submission.
Tech Stack 15 technologies
What Alvotech Is Building
◆Challenges
- Modernizing departmental operating model
- Ensuring cgmp compliance
- Inspection readiness
- Risk-proportionate quality assurance
- Process improvement and waste elimination
- Quality oversight across lifecycle
- Meeting regulatory audit requirements
- Continuous improvement of manufacturing excellence
- Regulatory audit compliance
- Budget constraints
▲Active Projects
- Modernizing departmental operating model
- Technology transfer
- Development of pv systems lifecycle management
- Setup new bioanalytical lab
- New product introduction
- Building specialized safety data management team
- Safety systems setup and lifecycle management
- Media fill simulations
- Validation protocol execution
- Dsp suite maintenance
Hiring Activity
Department
Seniority
Notable leadership hires: Scientific Director
